Notícias Windtree Therapeutics Inc - WINT | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Windtree Therapeutics Inc (WINT)
Windtree Therapeutics Inc (WINT) Notícias

Windtree Therapeutics Inc (WINT)

0,36

-0,02

(-5,26%)

Fechado 18 Dezembro 6:00PM

Atrasado por 15 minutos

0,3559

-0,0041

(-1,14%)

Após o horário de negociação: 9:06PM

Atrasado por 15 minutos

Discussões em tempo real e ideias de negociação: Negocie com confiança com nossa poderosa plataforma.

Windtree Announces Istaroxime Presentation By Cardiogenic Shock Thought Leader At Cardiovascular Clinical Trials Conference

Windtree Announces New Istaroxime Patent Filing for Preventing or Reducing the Risk of Acute Myocardial Arrhythmia

Form 8-K - Current report

Form 8-K - Current report

Windtree Announces Partnership with New Growth Advisors to Leverage Positive Phase 2 Istaroxime Study in Cardiogenic Shock for a Potential Strategic Transaction

Form 8-K - Current report

Windtree Therapeutics Reports Third Quarter 2024 Financial Results and Provides Key Business Updates

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 8-K - Current report

Windtree Announces Leadership Transition Plan With Industry Veterans

Windtree Announces Expansion of Patents with Issuance of Istaroxime Patent for Hong Kong

Windtree Therapeutics Initiates SEISMiC C Study of Istaroxime in SCAI Stage C Cardiogenic Shock for Planned Completion of Phase 2b and Transition to Phase 3

Windtree Announces Istaroxime Cardiogenic Shock Patent Filings In Countries Around the World

Windtree To Present at the ThinkEquity Conference on October 30th

Windtree Announces Expansion of Patents with Issuance of Istaroxime Patent for Japan

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Windtree Therapeutics

Defiance Quantum ETF

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições